The chemistry and biology of the fumonisin family of natural products has inspired an integrated research program featuring methods development for stereoselective synthesis of homoallylic alcohols, accompanied by applications of these methods to the first synthesis of fumonisin B 1 , and to preparing a family of stereoisomeric 2-amino-3,5-diol analogs of 1-deoxysphingolipids, as a possible approach to discovering new drugs for cancer chemotherapy.
INTRODUCTION
The fumonisins are a family of natural products produced by Fusarium verticillioides, a fungus that contaminates corn and food sources, including rice, sorghum, wheat bran, and soybean meal, and poultry feed [1] . The World Health Organization has established the tolerable daily intake of total fumonisins at 2 μg/kg body weight per day, and the tolerance value in dry corn products is set at 1 ppm of total fumonisins. More than three dozen fumonisins are known, with the most abundant and most toxic member as fumonisin B 1 (1, Fig. 1 ). The basic structure of fumonisin B 1 has been characterized by South African scientists [2] , with stereochemistry subsequently determined by the laboratories of Hoye and Kishi [3] . A structurally related compound, AAL toxin (7) , is produced by Alternaria alternata, a fungal parasite of tomatoes [4] . Diseases associated with fumonisin exposure include esophageal cancer and neural tube birth defects in humans [5] , as well as equine leukoencephalomalacia (liquifaction of cerebrum white matter) and porcine pulmonary edema associated with left ventricle heart failure [6] . However, N-acyl derivatives (such as fumonisin A 1 , 5) are not cancer initiators, and saponification of the tricarballylic esters to aminopentol-1 (8) also reduces toxicity as well as cancer initiation activity [7] . The biological effects of fumonisins are attributed to disruptive effects on sphingolipid metabolism (Fig. 2) . Specifically, ceramide synthase enzymes are inhibited, thus lowering the concentration of ceramide, which signals cell cycle arrest, apoptosis, senescence, and differentiation [8] . Notably, fumonisin B 1 is not a substrate for ceramide synthases (Fig. 3) , in contrast to aminopentol-1 (12) , which upon treatment with radiolabeled palmitoyl-CoA does give the N-palmitoyl derivative (13) . In evaluating the in vitro cytotoxic activity of these compounds against HT-29 cells (human colon cancer), N-palmitoylaminopentol-1 (13) reduces cell number by >90 % at 50 μM concentration. 
FUMONISIN AS A TEMPLATE FOR METHODOLOGY DEVELOPMENT
With this background in mind, we embarked on a research program directed toward the laboratory syntheses of aminopentol-1 (12) and fumonisin B 1 (1), as well as simple analogs of aminopentol-1 as 1-deoxysphingolipid analogs [9] . In considering the synthesis of two fragments 14 and 15 to be connected at C9-C10 (Fig. 4) , we encountered a common theme of homoallylic alcohols 16 and 17, requir- ing stereocontrol of the chiral secondary alcohols as well as the 1,2-disubstituted alkenes. We proposed that an efficient synthesis would control both stereochemical elements in a single transformation. To this end, several laboratories previously explored the synthesis of homoallylic alcohols utilizing stereospecific pericyclic rearrangements [10] . Specifically, the oxonia-Cope rearrangement (Fig. 5 ) offered promising grounds for an allylic transfer process, although the Prins cyclization could be a competing process in the presence of a nucleophile (:Nu). The first precedents for this allylic transfer process were reported by Nokami over a decade ago, in which the kinetic α-aldol product 29 generated by deconjugative aldol reaction underwent Lewis acid-catalyzed rearrangement to the thermodynamically favored γ-aldol regioisomer [11] . Moreover, a transfer process into a saturated aldehyde 30 provided allylic transfer to produce benzaldehyde (35) as a byproduct along with products 31 and 32 (Scheme 1). This work also established that diastereomerically pure samples of the aldol compounds 29 underwent stereospecific reaction to give either the cis-alkene of lactone 31 or the trans-alkene of alcohol 32. However, the product yields for compounds 31 and 32 were diminished by internal rearrangement processes.
We proposed that a tethered oxygen nucleophile might intercept the product side of the oxoniaCope rearrangement equilibrium, thus driving the reaction exclusively with a new acceptor aldehyde. The idea was successfully realized in the context of synthesizing bispropionate structures, albeit with the surprising formation of a seven-membered ring acetal intermediate 38 upon tin(II) triflate-catalyzed reaction of 36 with 1 equiv of isobutyraldehyde (37, Scheme 2) [12] . This acetal was stable to tin(II) triflate, but upon reaction with stronger Lewis acidic conditions, the expected product was generated in good yield and with virtually perfect stereospecific translation of all stereochemical elements. For instance, the anti-stereochemistry of compound 36 resulted in the E-alkene of product 39, whereas the syn-diastereomer of 36 resulted in clean formation of the Z-alkene, isolated as the unsaturated lactone (not shown). Likewise, the trans-alkene of compound 36 was expressed as the anti-diastereomer of product 39.
In extending the scope of this transformation, we prepared the cis-alkene reagent 40 (Scheme 3) [13] . Although the reaction with isobutyraldehyde proceeded with the expected syn-diastereoselectivity in compound 42, the product yield was relatively low.
We then wondered if a saturated tether to the nucleophilic oxygen would be sufficient for the reaction, as in synthon 43 (Scheme 4). Indeed, the expected transformation occurred, and compound 42 was produced in substantially better yield. From this stage forward, the aldehyde precursor to this tether, 4-silyloxybutanal (45), became our preferred "disposable aldehyde".
For the C10-C20 sector of fumonisin B 1 corresponding to structure 17 in our retrosynthetic analysis (Fig. 4) , we prepared the synthon 48 (Scheme 5) as a single stereoisomer, utilizing deconjugative aldol reaction of the N-crotonyloxazolidone 46 [14] with disposable aldehyde 45, followed by removal of the chiral auxiliary from 47 leading to the methyl ester 48. The acceptor aldehyde 51 was prepared in straightforward fashion from 2-hepten-1-ol (49), with Sharpless-Katsuki titanium-tartrate epoxidation [15] followed by regioselective addition with trimethylaluminum [16] , setting the chiral centers at C15 and C16. Regioselective reductive cleavage of the benzylidene acetal 50 revealed the primary alcohol precursor to aldehyde 51.
The allylic transfer reaction proceeded with equimolar amounts of 48 and 51 under optimized conditions using trimethylsilyl trifluoromethanesulfonate (TMSOTf), providing product 52 with transalkene selectivity and only one diastereomer (Scheme 6). The seven-membered ring acetal 53 was formed as the initial product with catalytic TMSOTf, but upon reaction with a full equivalent of TMSOTf, the transformation directly provided 52, consistent with rearrangement of oxonium ion intermediate 54.
For the C1-C9 sector, we envisioned mechanistically similar methodology for preparing the cis-alkenyl alcohol corresponding to compound 16 in our retrosynthetic analysis (Fig. 4) . Indeed, a camphor-derived crotyl-transfer reagent 55 developed by Loh [17] provided the desired product 57, although this transformation required 5-6 days for complete conversion of the aldehyde 56 (Scheme 7). Scheme 6 Application of the γ-vinylogous aldol synthon to prepare compound 52.
As other allylic transfer methods had proceeded with much faster rates, we sought to determine if a simplified synthon 58 (Scheme 8) would give better results. Thus, enantio-and diastereoselective crotylboration [18] of our disposable aldehyde 45 provided the branched homoallylic alcohol 58 with high stereoselectivity. Upon reaction with camphorsulfonic acid (CSA), once again the seven-membered ring acetal 61 was formed, but with a full equivalent of CSA and stirring for a full day, crotyl transfer occurred to provide product 59 as only the cis-alkene, and with enantio selectivity equivalent to the stereochemical purity of synthon 58 [19] . For the first time, we also observed the cyclic tetrahydrofuranyl acetal 60, albeit as a minor byproduct, but consistent with nucleo philic trapping of the product oxonium ion 63 by the pendant hydroxyl group. Although the best yields of 59 resulted from CSA, the reactions were considerably quicker when conducted with 0.4 equiv of Sn(OTf) 2 (1 h at 20 °C, 42 % yield of 59) or with 1 equiv of TMSOTf (less than 30 min at 0 °C, 40 % yield of 59).
In order to prepare the diastereomeric synthon with the highest stereoselectivity, Mitsunobu reaction [20] of 58 followed by reductive cleavage of the ester afforded synthon 64 exclusively as the antidiastereomer (Scheme 9). The reaction of 64 with tetradecanal proceeded with complete stereoselectivity for the trans-homoallylic alcohol 65, accompanied by the tetrahydrofuranyl acetal byproduct 66.
In our application of synthon ent-58 to the synthesis of the C1-C9 sector of fumonisin, we observed that the silylalkyne somehow inhibited the reaction, so as of this writing, the procedure described in Scheme 7 utilizing the camphor-based reagent has provided better throughput of the enynol 57 (Scheme 10). We deliberately prepared the C5-alcohol with (S)-configuration, opposite to that observed in fumonisin aminopentol, as the best method for highly stereoselective epoxidation of the cis-alkene of 57 utilized hydroxyl-directed vanadium-catalyzed epoxidation [21] , to afford epoxyalcohol 67, which was converted into the desired diastereomer 68 by Mitsunobu reaction at C5. Although Sharpless had reported titanium-promoted regioselective additions of azide to glycidols [22] , this method had never been reported for epoxides of homoallylic alcohols. In our case with epoxyalcohol 68, regioselectivity was modest, favoring 70 in a 2.5:1 mixture of regioisomers. (The paper will later return to this step.) Benzyl ether protection of C3 and C5 diol and desilylation revealed the terminal alkyne of 71, which would be utilized to cross-couple this C1-C9 section with C10-C20.
For the synthesis of the aminopentol-1 (Scheme 11), the homoallylic alcohol 52 (from Scheme 6) was protected as the benzyl ether under mild conditions [23] , as compound 52 was susceptible to retroaldol reaction under basic conditions. Enantioselective conjugate addition [24] introduced the methyl at C12, and the ester was converted into the Weinreb amide 72 for C9-C10 bond construction [25] . Deprotonation of the terminal alkyne of C1-C9 sector 71 and addition of the resulting alkynyllithium to compound 72 afforded the yne-one 73, bearing all of the carbon, nitrogen, and oxygen atoms of aminopentol-1. Enantioselective ketone reduction [26] provided the propargylic alcohol 74 as the major component of a 9:1 mixture, and global hydrogenolysis/hydrogenation of the azide, alkyne, and four benzyl ethers provided the aminopentol-1 (12), which matched the physical and spectroscopic properties of a sample obtained from the saponification of fumonisin B 1 . For the synthesis of fumonisin B 1 (Scheme 12), the protective group pattern at C14 and C15 needed to be orthogonal from the other oxygen protective groups, for late-stage introduction of the tricarballylic esters. Thus, the benzyl ethers of 75 were removed and the diol was reprotected as the acetonide, prior to formation of the Weinreb amide 76. As described before, addition of the alkynyllithium derived from 71 and enantioselective reduction of the ketone of 77 afforded the propargylic alcohol 78. Benzyl ether formation at C10 was followed by acetonide hydrolysis to reveal the C14,C15-diol, for acylation with the dibenzyl diester tricarballylic ester synthon 80 [27] , to give compound 81. Global hydrogenation/hydrogenolysis of azide, alkyne, three benzyl ethers, and four benzyl esters completed the first laboratory synthesis of fumonisin B 1 (1) [28] .
Given the anticancer and antimicrobial actions of several 1-deoxysphingolipid natural products (82, 83, Fig. 7) [31,32], fumonisins and aminopentol-1 (12) were considered as structurally complex 1-deoxysphingolipid analogs. Based on their observations of the anticancer activity of N-palmitoylaminopentol from the ceramide synthase-catalyzed N-acylation of aminopentol-1 (12), the Merrill and Liotta laboratories proposed 2-aminooctadecane-3,5-diol (84, Fig. 8 ), projected to have lipophilicity similar to that of sphingosine, as a simplified analog of fumonisins and aminopentol-1 [33].
Although several syntheses were known for the aminodiol 84 [33, 34] , which Merrill dubbed "enigmols", we sought to utilize the products arising from our allylic transfer methodology developed in our fumonisin and aminopentol-1 syntheses to prepare a family of diastereomers, to explore the anticancer activity of these compounds. To this end, compound ent-59 underwent hydroxyl-directed epoxidation to epoxyalcohol 85 and Mitsunobu inversion to 86 (Scheme 13), whereas the trans-alkene 65 and its enantiomer underwent Shi enantioselective epoxidation [35] to afford 87 and 88. For the cis-epoxides 85 and 86, titanium-promoted azide additions provided only modest selectivities for the C2-azide regioisomers 89 and 90. However, azide additions to trans-epoxides 87 and 88 were much more highly regioselective, perhaps due to diminished steric interactions at C2 of the trans-epoxides. Lithium aluminum hydride reduction of each azide afforded pure samples of each diastereomeric 2-amino-3,5-diol 93-96. Cytotoxicity of each aminodiol diastereomer was evaluated against DU145 (prostate cancer) and HT29 (colon cancer) cell lines vs. sphingosine 8 as the control (Fig. 9 ). For both cell lines, the S,S,S-isomer 93 showed inhibition at levels superior to sphingosine as well as the other diastereomers, includ- ing the diastereomer 94 corresponding to the stereochemistry of fumonisin. Enigmol 93 was subsequently studied more extensively by our collaborators, including in vivo studies on nude mice with prostate cancer xenografts, which revealed that 93 was orally deliverable, showing significant inhibition of tumor growth, without any signs of toxicity [36] .
CONCLUSIONS
This paper has described an integrated program in synthetic methodology, natural products synthesis, and medicinal chemistry. In this work, a new family of synthons has been described for the simultaneous generation of di-and trisubstituted alkenes along with chiral secondary homoallylic alcohols, and applied to the first laboratory synthesis of the most complex and most abundant of the fumonisin natural products. Further studies are directed toward improving the potency and selectivity of these aminodiol analogs, in our efforts to discover new and effective drugs for cancer chemotherapies.
